Showing results (11-20 of 288) with videos related to
Sort By:
Pageof 29
Immunology|March 28, 2007
Cancer immunoediting from immune surveillance to immune escapeRyungsa Kim, Manabu Emi, Kazuaki TanabeCancer Biology & Therapy|September 24, 2005
Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responsesRyungsa Kim, Manabu Emi, Kazuaki TanabeCancer Chemotherapy and Pharmacology|September 22, 2005
Role of mitochondria as the gardens of cell deathRyungsa Kim, Manabu Emi, Kazuaki TanabeChildren (Basel, Switzerland)|May 4, 2026
The Benefits of the Positive Parenting Program as Early Intervention for Mothers of Children Aged 1-3 Years Who May Have Neurodevelopmental DisordersHiromi Masuda, Kazuaki Tanabe, Yukari NakanoOncology Reports|May 13, 2004
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIBRyungsa Kim, Akihiko Osaki, Kazuaki Tanabe, et al.Cancer|October 27, 2004
Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapyRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.The Lancet. Oncology|December 2, 2006
Immunobiology of the sentinel lymph node and its potential role for antitumour immunityRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 15, 2022
Successful Transcatheter Aortic Valve Replacement Approached Via a Simultaneously Implanted Y-graft Vascular ProsthesisHiroshi Kawahara, Akihiro Endo, Shoichi Suehiro, et al.Cancer Research|June 3, 2006
Tumor-driven evolution of immunosuppressive networks during malignant progressionRyungsa Kim, Manabu Emi, Kazuaki Tanabe, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Therapeutic potential of antisense (AS) Bcl-2 as a chemosensitizer for patients with gastric and breast carcinoma]Ryungsa Kim, Manabu Emi, Kazuo Matsuura, et al.Pageof 29